PRF Technologies Ltd.
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About PRF Technologies
Pharmaceutical Preparations, SIC 2834
PRF Technologies Ltd., previously known as PainReform, operates in clinical pharmaceutical development and solar artificial intelligence software. Through its drug development operations, the company works on advancing therapeutic candidates such as OcuRing-K and PRF-110, alongside biopharmaceutical assets acquired through Layerbio, Inc. In its technology segment, the company commercializes the DeepSolar AI software platform, which delivers analytics and automated solutions for solar energy systems. Its target customers comprise participants within the renewable solar energy industry as well as prospective healthcare patients and providers.
The company engages in business activities across drug development and solar technology infrastructure. Its operations and assets connect Israel with international markets, including subsidiaries and agreements linked to the United States. PRF Technologies Ltd. maintains its corporate headquarters and principal executive offices in Tel Aviv, Israel.
Summary of the business section of PRF Technologies's latest annual report, written by StockData.
Company profile
Company
- Legal name
- PRF Technologies Ltd.
- Headquarters
- Tel Aviv, Israel
- Address
- 65 Yigal Alon St.
- Phone
- 972-3-7177051
- Employees
- 6, Dec 31, 2025
- Industry
- Pharmaceutical Preparations
- Incorporated in
- L3
- Fiscal year ends
- December 31
- Auditor
- Kesselman & Kesselman, Tel-Aviv, Israel
Stock & identifiers
- Ticker
- PRFX
- Exchange
- Nasdaq
- IPO date
- Sep 2, 2020
- Shares outstanding
- 1M, Dec 31, 2025
- Filer category
- Non-accelerated filer
- Stock splits
- 1-for-5 reverse, Feb 6, 2026; 1-for-7.75 reverse, Apr 7, 2025; 1-for-6 reverse, Sep 9, 2024; 1-for-9.75 reverse, Aug 10, 2023; 1-for-10 reverse, Jul 3, 2023
- SEC CIK
- 1801834
- CUSIP
- M77798144
- ISIN
- USM777981442
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Efraim Cohen-Arazi | Interim CEO, Director | – |
| Ehud Geller | Exec Chairman of the Board, Director | – |
| Eyal Broder | Chief Financial Officer | – |
| Sigal Aviel | Chief Operating Officer | – |
| Asaf Shavit | Director | – |
| Ellen S. Baron | Director | – |
| Augustine Lawlor | Director | – |
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had six full-time employees and one part time employees engaged in research and development, operations, and administration.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jan 20, 2026 | Name change | Name changed from PAINREFORM LTD. to PRF Technologies Ltd. |
| Sep 2, 2020 | IPO | Initial public offering priced (424B4 prospectus) |
| Aug 31, 2020 | Listing | Registration of securities on an exchange (Form 8-A) |